Samsung Biologics, “We will become the top CSO by 2020”

Published: 2015-11-06 15:36:12

Updated: 2015-11-06 15:47:12

Samsung Biologics which takes change in the Samsung Group’s biopharmaceutical manufacturing business announced a goal to become the top in the biopharmaceutical ‘Contract Manufacturing Organization(CMO)’ by 2020.

CEO Tae-han Kim of Samsung Biologics announced the plan when he stood as a speaker at the Samsung’s ‘Play the Challenge’ talk concert at Chungnam University on the 4^th.

“Established ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.